Qureator was recently featured in The Chosun Daily for its cutting-edge human disease modeling platform that replicates complex tissue microenvironments using organ-on-a-chip technology. By combining vascularized 3D organoids with AI-driven analytics, Qureator enables high-throughput, clinically relevant drug screening—offering a transformative alternative to traditional animal models. The article highlights our success in modeling drug response in gastrointestinal cancers, including both treatment-sensitive and resistant cases. We’re honored by this recognition and remain committed to accelerating precision medicine through human-relevant platforms. Special thanks to our team, collaborators, and partners who continue to drive our mission forward.
https://www.chosun.com/special/special_section/2024/03/18/YFQDEZGBIRF5TAHULKERDNCTEM/
